Literature DB >> 17684012

Mitogen-activated protein kinase p38 regulates the Wnt/cyclic GMP/Ca2+ non-canonical pathway.

Li Ma1, Hsien-yu Wang.   

Abstract

The non-canonical Wnt/cyclic GMP/Ca(2+)/NF-AT pathway operates via Frizzled-2, a member of the superfamily of G protein-coupled receptors. In scanning for signaling events downstream of the Frizzled-2/G alpha t2/PDE6 triad activated in response to Wnt5a, we observed a strong activation of the mitogen-activated protein kinase p38 in mouse F9 teratocarcinoma embryonal cells. The activation of p38 is essential for NF-AT transcriptional activation mediated via Frizzled2. Wnt5a-stimulated p38 activation was rapid, sensitive to pertussis toxin, to siRNA against either G alpha t2 or p38 alpha, and to the p38 inhibitor SB203580. Real-time analysis of intracellular cyclic GMP using the Cygnet2 biosensor revealed p38 to act at the level of cyclic GMP, upstream of the mobilization of intracellular Ca(2+). Fluorescence resonance energy transfer (FRET) imaging reveals the changes in cyclic GMP in response to Wnt5a predominate about the cell membrane, and likewise sensitive to either siRNA targeting p38 or to treatment with SB203580. Dishevelled is not required for Wnt5a activation of p38; siRNAs targeting Dishevelleds and expression of the Dishevelled antagonist Dapper-1 do not suppress the p38 response to Wnt5a stimulation. These novel results are the first to detail a Dishevelled-independent Wnt response, demonstrating a critical role of the mitogen-activated protein kinase p38 in regulating the Wnt non-canonical pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17684012     DOI: 10.1074/jbc.M702840200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Regulation of tenascin expression in bone.

Authors:  Jessica M Morgan; Alice Wong; Clare E Yellowley; Damian C Genetos
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

Review 2.  Non-canonical Wnt signaling pathways in hematopoiesis.

Authors:  Kathleen Kokolus; Michael J Nemeth
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

Review 3.  Potential protective mechanisms of aryl hydrocarbon receptor (AHR) signaling in benign prostatic hyperplasia.

Authors:  Vatsal Mehta; Chad M Vezina
Journal:  Differentiation       Date:  2011 Nov-Dec       Impact factor: 3.880

Review 4.  Cross-talk of calcium-dependent protein kinase and MAP kinase signaling.

Authors:  Bernhard Wurzinger; Andrea Mair; Barbara Pfister; Markus Teige
Journal:  Plant Signal Behav       Date:  2011-01-01

Review 5.  microRNA regulation of Wnt signaling pathways in development and disease.

Authors:  Jia L Song; Priya Nigam; Senel S Tektas; Erica Selva
Journal:  Cell Signal       Date:  2015-04-02       Impact factor: 4.315

6.  Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway.

Authors:  Dolores Fernández; Macarena Guereño; María Amparo Lago Huvelle; Magalí Cercato; María Giselle Peters
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-28       Impact factor: 4.553

7.  Common genetic variation in sFRP5 is associated with fat distribution in men.

Authors:  J K Van Camp; S Beckers; D Zegers; A Verrijken; L F Van Gaal; W Van Hul
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

8.  Mitogen-activated protein kinases and Wnt/beta-catenin signaling: Molecular conversations among signaling pathways.

Authors:  Rama Kamesh Bikkavilli; Craig C Malbon
Journal:  Commun Integr Biol       Date:  2009

9.  Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis.

Authors:  Sevdalina Nikolova; Andreas Guenther; Rajkumar Savai; Norbert Weissmann; Hossein A Ghofrani; Melanie Konigshoff; Oliver Eickelberg; Walter Klepetko; Robert Voswinckel; Werner Seeger; Friedrich Grimminger; Ralph T Schermuly; Soni S Pullamsetti
Journal:  Respir Res       Date:  2010-10-27

Review 10.  The opposing roles of Wnt-5a in cancer.

Authors:  S L McDonald; A Silver
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.